Use of Complementary Medicine in Pediatric Patients With Inflammatory Bowel Disease: Results From a Multicenter Survey
- 1 January 2009
- journal article
- research article
- Published by Wiley in Journal of Pediatric Gastroenterology and Nutrition
- Vol. 48 (1) , 55-60
- https://doi.org/10.1097/mpg.0b013e318169330f
Abstract
Objectives: We examined the use of complementary and alternative medicine (CAM) at 3 US pediatric medical centers, comparing a group of children with inflammatory bowel disease (IBD) with children presenting with chronic constipation. Materials and Methods: Surveys were administered by postal mail and at pediatric IBD centers in San Francisco, Houston, and Atlanta from 2001 to 2003. A comparison group consisting of pediatric patients with chronic constipation also was surveyed. Data were analyzed by t tests and by exact tests of contingency tables. Results: In all, 236 surveys were collected from the IBD group; 126 surveys were collected from the chronic constipation comparison group. CAM therapies were used by 50% in the IBD group and 23% in the chronic constipation group. The overall regional breakdown of CAM use in IBD revealed no differences, although the types of CAM therapy used varied by site. The most commonly used CAM therapies in the IBD group were spiritual interventions (25%) and nutritional supplements (25%). Positive predictors for CAM use in IBD include the patient's self-reported overall health, an increase in the number of side effects associated with allopathic medications, white ethnicity, and parental education beyond high school. Conclusions: This is the first US study to characterize CAM use in pediatric patients with IBD with another chronic gastrointestinal disorder. CAM use was twice as common with the IBD group compared with the chronic constipation group. Regional variations exist with the types of CAM therapy used. Practitioners should know that half of their pediatric patients with IBD may be using CAM in conjunction with or as an alternative to other treatments and that certain predictors can help identify those using CAM therapies.Keywords
Funding Information
- National Institutes of Health (DK 060617, DK 007762)
This publication has 17 references indexed in Scilit:
- Why patients with inflammatory bowel disease use or do not use complementary and alternative medicine: A Canadian national surveyCanadian Journal of Gastroenterology and Hepatology, 2005
- Children with early-onset inflammatory bowel disease (IBD): Analysis of a pediatric IBD consortium registryThe Journal of Pediatrics, 2005
- Use of complementary and alternative medicines by children and adolescents with inflammatory bowel diseaseJournal of Paediatrics and Child Health, 2004
- Patterns of Complementary and Alternative Medicine Use in a Population of Pediatric Patients with Inflammatory Bowel DiseaseInflammatory Bowel Diseases, 2004
- Visits to Complementary and Alternative Medicine Providers by Children and Adolescents in the United StatesAcademic Pediatrics, 2004
- Complementary and alternative medicine use among adults: United States, 2002.2004
- Complementary and Alternative Medicine Use by Canadian Patients With Inflammatory Bowel Disease: Results From A National SurveyAmerican Journal of Gastroenterology, 2003
- Use of Complementary and Alternative Medicine by Children in the United StatesArchives of Pediatrics & Adolescent Medicine, 2003
- Complementary medicine use in children and young adults with inflammatory bowel diseaseAmerican Journal of Gastroenterology, 2002
- Use of nonmedical treatment by cystic fibrosis patientsJournal of Adolescent Health, 1992